Accounts and other information Index 2010 Financial highlights 26 Group Income Statement 84 2011 Financial highlights 22 Group Notes to the Accounts 88 Accountability, Audit and Internal Control Framework 57, 60 Group overview 2 Accounting Policies 88 Group Statement of Changes in Equity 87 Accounts Presentation 88 Group Statement of Comprehensive Income 84 Acquisitions 121 Independent Auditors Reports 80, 82 Acquisition related costs 93 Information for shareholders 140 Advanced Wound Management Business segment review 38 Intangible assets 100 American Depository Shares 141, 143 Intellectual property 15 Articles of Association 149 Interest 95 Assets held for sale 122 Inventories 102 Audit fees 57, 94 Investments 101 Board 48 Investment in associates 102 Business overview 2, 4, 135 Investor information 137 Business Review 14 Key Performance Indicators 11 Business segment information 89 Leases 107, 122 Cash and borrowings 104 Legal proceedings 28 Chairmans statement 6 Manufacturing, supply and distribution 14 Chief Executive Ofcers statement 8 New accounting standards 89 Company Auditors Report 129 Off-Balance Sheet arrangements 136 Company Balance Sheet 130 Operating profit 93 Company Notes to the Accounts 131 Orthopaedics Business segment review 31 Contingencies 112 Other finance costs income 95 Contractual obligations 136 Outlook and trend information 41 Corporate Governance Statement 52 Parent Company accounts 129 Critical accounting policies 28 Payables 104 Cross Reference to Form 20-F 151 People Employees 43 Currency translation 88 Principal subsidiary undertakings 127 Deferred taxation 110 Provisions 112 Directors Remuneration Report 64 Property, plant and equipment 97, 135 Directors responsibilities for the accounts 78 Receivables 103 Directors responsibility statement 79 Recent developments 22 Dividends 119, 138 Regulation 18 Earnings per share 2, 96 Related party transactions 127, 136 Employees People 43 Research and development 15, 23, 93 Employees Share Trust 119 Restructuring and rationalisation expenses 94 Endoscopy Business segment review 35 Retirement benefit obligation 113 Exchange and interest rate risk and financial instruments 15 Risk factors 16 Executive ofcers 50 Risk management 12 Factors affecting results of operations 16 Sales and marketing 14 Financial instruments 107 Selected financial data 145 Financial position, liquidity and capital resources 25 Share based payments 123 Financial highlights 20 Share capital 118, 143 Glossary of terms 153 Shareholder return 138 Goodwill 98 Strategy 10 Governance and policy 46 Sustainability 42 Group Balance Sheet 85 Taxation 23, 95 Group Cash Flow Statement 86 Taxation information for shareholders 147 Group history 135 Treasury shares 119 155 Smith & Nephew Annual Report 2011 Accounts and other information Corporate Governance Business Review Strategy, KPIs & Risk management Overview About Smith & Nephew The Smith& Nephew Group the Group is a global medical devices ForSmith & Nephew, these factors include: economic and financial business operating in the markets for orthopaedic reconstruction and conditions in the markets we serve, especially those affecting health care trauma, endoscopy which includes arthroscopic procedures referred to as providers, payers and customers: price levels for established and sports medicine and advanced wound management, with revenue of innovative medical devices: developments in medical technology: approximately $4 billion in 2011.
Smith& Nephew plc the Company is regulatory approvals, reimbursement decisions or other government the parent company of the Group.
It is an English public limited company actions: product defects or recalls: litigation relating to patent or other with its shares listed on the premium list of the UK Listing Authority and claims: legal compliance risks and related investigative, remedial or traded on the London Stock Exchange.
Shares are also traded on the New enforcement actions: strategic actions, including acquisitions and York Stock Exchange in the form of American Depositary Shares ADSs.
dispositions and our success in integrating acquired businesses: and numerous other matters that affect us or our markets, including those of a This is the Annual Report of Smith& Nephew plc for the year ended political, economic, business or competitive nature.
It comprises, in a single document, the Annual Report the Group are described under Risk factors on pages16 to 18 of this and Accounts of the company in accordance with UK requirements and the Annual Report.
Any forward-looking statement is based on information Annual Report on Form 20-F in accordance with the regulations of the available to Smith& Nephew as of the date of the statement.
All written or United States Securities and Exchange Commission SEC.
oral forward-looking statements attributable to Smith & Nephew are Smith& Nephew operates on a worldwide basis and has distribution qualied by this caution.
Smith & Nephew does not undertake any channels in over 90 countries.
In the more established countries by obligation to update or revise any forward-looking statement to reect any revenue, the Groups business operations are organised by Business change in circumstances or in Smith & Nephews expectations.
In the majority of the remaining markets, operations are managed by country managers who are responsible for sales and Segment data distribution of the Groups entire product range.
These comprise the Segment data and segment share estimates throughout this report are Emerging Markets and International Markets.
derived from a variety of sources including publicly available competitors information, internal management information and independent market Smith& Nephews corporate website, www.
additional information on the Group, including an electronic version of this Annual Report.
Information made available on this website, or other websites mentioned in this Annual Report, are not, and should not be Documents on display regarded as being, part of or incorporated into this Annual Report.
It is possible to read and copy documents referred to in this Annual Report at the Registered Ofce of the Company.
Documents referred to in this For the convenience of the reader, a Glossary of technical and financial Annual Report that have been led with the Securities and Exchange terms used in this document is included on pages 153 to 154.
The product Commission in the US may be read and copied at the SECs public names referred to in this document are identied by use of capital letters reference room located at 450 Fifth Street, NW, Washington DC 20549. and are trademarks owned by or licensed to members of the Group.
Please call the SEC at 1-800-SEC-0330 for further information on the public reference rooms and their copy charges.
The SEC also maintains a web site Presentation at www.
gov that contains reports and other information regarding The Groups scal year end is 31 December.
References in this Annual registrants that le electronically with the SEC.
This Annual Report and Report to a particular year are to the scal year unless otherwise indicated.
some of the other information submitted by the Group to the SEC may be Except as the context otherwise requires, Ordinary Share or share refer accessed through the SEC website.
to the Ordinary Shares of Smith& Nephew plc of 20 US cents each.
The Group Accounts of Smith& Nephew in this Annual Report are presented in US Dollars.
Solely for the convenience of the reader, certain parts of this Annual Report contain translations of amounts in US Dollars into Sterling at specified rates.
These translations should not be construed as representations that the US Dollar amounts actually represent such Sterling amounts or could be converted into Sterling at the rate indicated.
Except as where stated otherwise, the translation of US Dollars and cents to Sterling and pence appearing in this Annual Report has been made at the Bank of England exchange rate on the date indicated.
On 21 February 2012, the Bank of England rate was US$1.582 per 1.
The results of the Group, as reported in US Dollars, are affected by movements in exchange rates between US Dollars and other currencies.
The Group applied the average exchange rates prevailing during the year to translate the results of companies with functional currency other than US Dollars.
The currencies which most inuenced these translations in the years covered by this report were Sterling, Swiss Franc and the Euro.
The Accounts of the Group in this Annual Report are presented in millions m unless otherwise indicated.
Special note regarding forward-looking statements The Groups reports led with, or furnished to, the US Securities and Exchange Commission SEC, including this document and written information released, or oral statements made, to the public in the future by or on behalf of the Group, contain forward-looking statements within the meaning of the US Private Securities Litigation Reform Act of 1995, that may or may not prove accurate.
In particular, statements regarding expected revenue growth and trading profit margins discussed under Outlook and Trend Information, market trends and our product pipeline are forwardlooking statements.
Phrases such as aim, plan, intend, anticipate, well-placed, believe, estimate, expect, target, consider and similar expressions are generally intended to identify forward-looking statements.
Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results, to differ materially from what is expressed or implied by the statements.
156 Smith & Nephew Annual report 2011 The inks used are renewable, biodegradable and emit fewer Volatile Organic Compounds VOCs than mineral-oil inks.
They are based on high levels of renewable raw materials such as vegetable oils and naturally occurring resin.
The inks do not contain any toxic heavy metals and therefore, do not pose a problem if placed in landll.
Designed by Radley Yeldar Printed by RR Donnelley 262189 Smith & Nephew Annual report 2011 Smith & Nephew plc 15 Adam Street London WC2N 6LA United Kingdom T 44 0 20 7401 7646 F 44 0 20 7960 2350 www.
